Request for Covid-19 Impact Assessment of this Report

Take Action
Healthcare

Global Active Pharmaceutical Ingredients Market Size study, by Type of Synthesis (Biotech, Synthetic, Vaccines, Monoclonal Antibodies and Recombinant Proteins), by Type of Manufacturer (Captive API and Merchant API), by Type (Generic and Innovative APIs), by Application (Cardiovascular Diseases, Oncology, Orthopedics, Nephrology and Others), and Regional Forecasts 2021-2027

  • BIZ4386161
  • 200 Pages
  • May 2021
  • Healthcare
Download Sample    Get Discount   
 
Global Active Pharmaceutical Ingredients Market is valued approximately USD 184.8 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 6.90% over the forecast period 2021-2027. Active pharmaceutical ingredient is a substance or mixture of substances used in the manufacturing of a medicinal drug and becomes an active ingredient of the drug product, when used in the production of a drug. APIs are intended to furnish pharmacological activity or any other direct effect in the analysis, treatment, mitigation, diagnosis or prevention of a disease. The APIs are the building blocks of pharmaceutical industry. The exponential growth of the industry after the COVID-19 pandemic has increased the demand of APIs. Pharmaceutical supply chain was heavily disrupted during lockdowns in pandemic which resulted in shortage of APIs worldwide. The various governments, including Indian and other Asian countries, are now trying to ramp up the growth of APIs domestically to reduce the dependency on China. These efforts are also driving the growth of active pharmaceutical ingredients market. In 2020, Government of India announced Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of APIS, in which financial incentive will be given to eligible manufacturers of identified 41 eligible products which covers 53 APIs for 6 years. Another scheme from government allots INR 3000 Crores for providing financial assistance for construction of Common Infrastructure Facilities in 3 Bulk Drug Parks.

The high cost of setting up API production units and stringent safety regulations and governmental norms may act as a restraint for its growth. However, increasing chronic diseases due to lifestyle changes such as cardiovascular, respiratory and others act as an opportunity for growth of Active Pharmaceutical Ingredients Market in subsequent decade.

Key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World are analysed to provide a holistic picture of Active Pharmaceutical Ingredients Market. Due to the presence of leading pharmaceutical formulation manufacturers as well as rise of lifestyle diseases, North America is a significant region across the world in terms of market share. Whereas, Asia-Pacific is expected to exhibit highest growth rate for the forecast period 2021-2027 owing to the growing pharmaceuticals industries in emerging economies of China and India. Government backed schemes and policies will also boost growth of API market in this region.

Major market player included in this report are:

AbbVie, Inc.

Boehringer Ingelheim International GmbH

Bristol-Myers Squibb Company

Cipla, Inc.

Merck & Co., Inc.

Albemarle Corporation

Aurobindo Pharma

Viatris Inc. (Mylan N.V.)

Teva Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type of Synthesis:

Biotech API

Monoclonal Antibodies

Recombinant Proteins

Vaccines

Synthetic API

By Type of Manufacturer:

Captive API

Merchant API

By Type:

Generic APIS

Innovative APIs

By Application:

Cardiovascular Diseases

Oncology

CNS and Neurology

Orthopedics

Endocrinology

Pulmonology

Gastroenterology

Nephrology

Ophthalmology

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019

Base year – 2020

Forecast period – 2021 to 2027

Target Audience of the Global Active Pharmaceutical Ingredients Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)

1.2.1. Active Pharmaceutical Ingredients Market, by Type of Synthesis, 2019-2027 (USD Billion)

1.2.2. Active Pharmaceutical Ingredients Market, by Type of Manufacturer, 2019-2027 (USD Billion)

1.2.3. Active Pharmaceutical Ingredients Market, by Type, 2019-2027 (USD Billion)

1.2.4. Active Pharmaceutical Ingredients Market, by Application, 2019-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Active Pharmaceutical Ingredients Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Active Pharmaceutical Ingredients Market Dynamics

3.1. Active Pharmaceutical Ingredients Market Impact Analysis (2019-2027)

3.1.1. Market Drivers

3.1.1.1. Exponential growth of pharmaceutical industry

3.1.1.2. Governmental proposed policies and schemes

3.1.2. Market Challenges

3.1.2.1. High cost of production of APIs

3.1.3. Market Opportunities

3.1.3.1. Increase in lifestyle diseases such as diabetes and cardiovascular

Chapter 4. Global Active Pharmaceutical Ingredients Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Active Pharmaceutical Ingredients Market, by Type of Synthesis

5.1. Market Snapshot

5.2. Global Active Pharmaceutical Ingredients Market by Type of Synthesis, Performance - Potential Analysis

5.3. Global Active Pharmaceutical Ingredients Market Estimates & Forecasts by Type of Synthesis 2018-2027 (USD Billion)

5.4. Active Pharmaceutical Ingredients Market, Sub Segment Analysis

5.4.1. Biotech API

5.4.2. Monoclonal Antibodies

5.4.3. Recombinant Proteins

5.4.4. Vaccines

5.4.5. Synthetic API

Chapter 6. Global Active Pharmaceutical Ingredients Market, by Type of Manufacturer

6.1. Market Snapshot

6.2. Global Active Pharmaceutical Ingredients Market by Type of Manufacturer, Performance - Potential Analysis

6.3. Global Active Pharmaceutical Ingredients Market Estimates & Forecasts by Type of Manufacturer 2018-2027 (USD Billion)

6.4. Active Pharmaceutical Ingredients Market, Sub Segment Analysis

6.4.1. Captive API

6.4.2. Merchant API

Chapter 7. Global Active Pharmaceutical Ingredients Market, by Type

7.1. Market Snapshot

7.2. Global Active Pharmaceutical Ingredients Market by Type, Performance - Potential Analysis

7.3. Global Active Pharmaceutical Ingredients Market Estimates & Forecasts by Type 2018-2027 (USD Billion)

7.4. Active Pharmaceutical Ingredients Market, Sub Segment Analysis

7.4.1. Generic APIS

7.4.2. Innovative APIs

Chapter 8. Global Active Pharmaceutical Ingredients Market, by Application

8.1. Market Snapshot

8.2. Global Active Pharmaceutical Ingredients Market by Application, Performance - Potential Analysis

8.3. Global Active Pharmaceutical Ingredients Market Estimates & Forecasts by Application 2018-2027 (USD Billion)

8.4. Active Pharmaceutical Ingredients Market, Sub Segment Analysis

8.4.1. Cardiovascular Diseases

8.4.2. Oncology

8.4.3. CNS and Neurology

8.4.4. Orthopedics

8.4.5. Endocrinology

8.4.6. Pulmonology

8.4.7. Gastroenterology

8.4.8. Nephrology

8.4.9. Ophthalmology

8.4.10. Others

Chapter 9. Global Active Pharmaceutical Ingredients Market, Regional Analysis

9.1. Active Pharmaceutical Ingredients Market, Regional Market Snapshot

9.2. North America Active Pharmaceutical Ingredients Market

9.2.1. U.S. Active Pharmaceutical Ingredients Market

9.2.1.1. Type of Synthesis breakdown estimates & forecasts, 2018-2027

9.2.1.2. Type of Manufacturer breakdown estimates & forecasts, 2018-2027

9.2.1.3. Type breakdown estimates & forecasts, 2018-2027

9.2.1.4. Application breakdown estimates & forecasts, 2018-2027

9.2.2. Canada Active Pharmaceutical Ingredients Market

9.3. Europe Active Pharmaceutical Ingredients Market Snapshot

9.3.1. U.K. Active Pharmaceutical Ingredients Market

9.3.2. Germany Active Pharmaceutical Ingredients Market

9.3.3. France Active Pharmaceutical Ingredients Market

9.3.4. Spain Active Pharmaceutical Ingredients Market

9.3.5. Italy Active Pharmaceutical Ingredients Market

9.3.6. Rest of Europe Active Pharmaceutical Ingredients Market

9.4. Asia-Pacific Active Pharmaceutical Ingredients Market Snapshot

9.4.1. China Active Pharmaceutical Ingredients Market

9.4.2. India Active Pharmaceutical Ingredients Market

9.4.3. Japan Active Pharmaceutical Ingredients Market

9.4.4. Australia Active Pharmaceutical Ingredients Market

9.4.5. South Korea Active Pharmaceutical Ingredients Market

9.4.6. Rest of Asia Pacific Active Pharmaceutical Ingredients Market

9.5. Latin America Active Pharmaceutical Ingredients Market Snapshot

9.5.1. Brazil Active Pharmaceutical Ingredients Market

9.5.2. Mexico Active Pharmaceutical Ingredients Market

9.6. Rest of The World Active Pharmaceutical Ingredients Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies

10.2. Company Profiles

10.2.1. AbbVie, Inc.

10.2.1.1. Key Information

10.2.1.2. Overview

10.2.1.3. Financial (Subject to Data Availability)

10.2.1.4. Product Summary

10.2.1.5. Recent Developments

10.2.2. Boehringer Ingelheim International GmbH

10.2.3. Bristol-Myers Squibb Company

10.2.4. Cipla, Inc.

10.2.5. Merck & Co., Inc.

10.2.6. Albemarle Corporation

10.2.7. Aurobindo Pharma

10.2.8. Viatris Inc. (Mylan N.V.)

10.2.9. Teva Pharmaceutical Industries Ltd.

10.2.10. Sun Pharmaceutical Industries Ltd.

Chapter 11. Research Process

11.1. Research Process

11.1.1. Data Mining

11.1.2. Analysis

11.1.3. Market Estimation

11.1.4. Validation

11.1.5. Publishing

11.2. Research Attributes

11.3. Research Assumption

List of Tables

TABLE 1. Global Active Pharmaceutical Ingredients Market, report scope

TABLE 2. Global Active Pharmaceutical Ingredients Market estimates & forecasts by Region 2018-2027 (USD Billion)

TABLE 3. Global Active Pharmaceutical Ingredients Market estimates & forecasts by Type of Synthesis 2018-2027 (USD Billion)

TABLE 4. Global Active Pharmaceutical Ingredients Market estimates & forecasts by Type of Manufacturer 2018-2027 (USD Billion)

TABLE 5. Global Active Pharmaceutical Ingredients Market estimates & forecasts by Type 2018-2027 (USD Billion)

TABLE 6. Global Active Pharmaceutical Ingredients Market estimates & forecasts by Application 2018-2027 (USD Billion)

TABLE 7. Global Active Pharmaceutical Ingredients Market estimates & forecasts by 2018-2027 (USD Billion)

TABLE 8. Global Active Pharmaceutical Ingredients Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 9. Global Active Pharmaceutical Ingredients Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 10. Global Active Pharmaceutical Ingredients Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 11. Global Active Pharmaceutical Ingredients Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 12. Global Active Pharmaceutical Ingredients Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 13. Global Active Pharmaceutical Ingredients Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 14. Global Active Pharmaceutical Ingredients Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 15. Global Active Pharmaceutical Ingredients Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 16. Global Active Pharmaceutical Ingredients Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 17. Global Active Pharmaceutical Ingredients Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 18. U.S. Active Pharmaceutical Ingredients Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 19. U.S. Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 20. U.S. Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 21. Canada Active Pharmaceutical Ingredients Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 22. Canada Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 23. Canada Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 24. UK Active Pharmaceutical Ingredients Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 25. UK Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 26. UK Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 27. Germany Active Pharmaceutical Ingredients Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 28. Germany Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 29. Germany Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 30. RoE Active Pharmaceutical Ingredients Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 31. RoE Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 32. RoE Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 33. China Active Pharmaceutical Ingredients Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 34. China Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 35. China Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 36. India Active Pharmaceutical Ingredients Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 37. India Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 38. India Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 39. Japan Active Pharmaceutical Ingredients Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 40. Japan Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 41. Japan Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 42. RoAPAC Active Pharmaceutical Ingredients Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 43. RoAPAC Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 44. RoAPAC Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 45. Brazil Active Pharmaceutical Ingredients Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 46. Brazil Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 47. Brazil Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 48. Mexico Active Pharmaceutical Ingredients Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 49. Mexico Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 50. Mexico Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 51. RoLA Active Pharmaceutical Ingredients Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 52. RoLA Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 53. RoLA Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 54. Row Active Pharmaceutical Ingredients Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 55. Row Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 56. Row Active Pharmaceutical Ingredients Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 57. List of secondary sources, used in the study of global Active Pharmaceutical Ingredients Market

TABLE 58. List of primary sources, used in the study of global Active Pharmaceutical Ingredients Market

TABLE 59. Years considered for the study

TABLE 60. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Digital Pathology Market by Product (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication, Digital IVD Devices, and Others [Telepathology]), Type (Automated Hematology Analyzers & Blood Cell Counters, Chromosome Analyzers, FISH Enumeration Systems, Urine Sediment Analyzers, Immunohistochemistry Image Analysis Applications, Digital Cytopathology, Digital PCR, Signet Cell Detection, and Digital Holographic Microscopy), and End User (Educational, Clinical, and Pharma & Biotech Companies) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...

  • Publish Date: February 26, 2018
  • $5370
View Details
Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
View Details
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research